A. Lucci et al., “Circulating Tumour Cells in Non-metastatic Breast Cancer: A Prospective Study,” The Lancet Oncology 13, no. 7 (July 2012): 688–695.
S. J. Dawson et al., “Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer,” New England Journal of Medicine 368, no. 13 (2013): 1199–1209.
E. Grunfeld et al., “Population-Based Longitudinal Study of Follow-Up Care for Breast Cancer Survivors,” Journal of Oncology Practice 6, no. 4 (July 2010): 174–181.
LIVESTRONG, How Cancer Has Affected Post-treatment Survivors: A LIVESTRONG Report, https://d1un1nybq8gi3x.cloudfront.net/sites/default/files/what-we-do/reports/LSSurvivorSurveyReport.pdf.
Z. Koak and J. Overgaard, “Risk Factors of Arm Lymphedema in Breast Cancer Patients,” Acta Oncologica 39 (2000): 389–392.
T. DiSipio et al., “Incidence of Unilateral Arm Lymphoedema after Breast Cancer: A Systematic Review and Meta-analysis,” The Lancet Oncology 14, no. 6 (2013): 500–515.
M. T. Lacomba et al., “Effectiveness of Early Physiotherapy to Prevent Lymphoedema after Surgery for Breast Cancer: Randomised, Single Blinded, Clinical Trial,” British Medical Journal 340 (January 2010): b5396.
International Society of Lymphology, “The Diagnosis and Treatment of Peripheral Lymphedema. 2009 Concensus Document of the International Society of Lymphology,” Lymphology 42, no. 2 (2009): 51–60.
R. Ito and H. Suami, “Overview of Lymph Node Transfer for Lymphedema Treatment,” Plastic and Reconstructive Surgery 134, no. 3 (2014): 548–556.
S. L. Showalter et al., “Lifestyle Risk Factors Associated with Arm Swelling among Women with Breast Cancer,” Annals of Surgical Oncology 20, no. 3 (March 2013): 842–849.
C. M. Ferguson et al., “Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer,” Journal of Clinical Oncology 34, no. 7 (2015): 691–698.
S. Dhesy-Thind et al., “Use of Adjuvant Bisphosphonates and Other Bone Modifying Agents in Breast Cancer,” Journal of Clinical Oncology 35, no. 18 (June 2017): 2062–2081.
K. D. Crew, “Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast Cancer,” Journal of Clinical Oncology 25, no. 25 (September 2007): 3877–3883.
M. Seretny et al., “Incidence, Prevalence, and Predictors of Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-analysis,” PAIN 155, no. 12 (2014): 2461–2470.
D. Irvine et al., “The Prevalence and Correlates of Fatigue in Patients Receiving Treatment with Chemotherapy and Radiotherapy,” Cancer Nursing 17, no. 5 (October 1994): 367–378.
J. E. Bower et al., “Fatigue in Breast Cancer Survivors: Occurrence, Correlates, and Impact on Quality of Life,” Journal of Clinical Oncology 18, no. 4 (February 2000): 362.
D. S. Dizon, “Quality of Life after Breast Cancer: Survivorship and Sexuality,” The Breast Journal 15, no. 5 (September – October 2009): 500–504.
J. E. Dew, B. G. Wren, and J. A. Eden, “A Cohort Study of Topical Vaginal Estrogen Therapy in Women Previously Treated for Breast Cancer,” Climacteric 6, no. 1 (March 2003): 45–52.
A. Kendall et al., “Caution: Vaginal Estradiol Appears to Be Contraindicated in Postmenopausal Women on Adjuvant Aromatase Inhibitors,” Annals of Oncology 17, no. 4 (April 2006): 584–587.
A. Chang et al., “The Effect of Herbal Extract (EstroG‐100) on Pre‐, Peri‐ and Post‐Menopausal Women: A Randomized Double‐Blind, Placebo‐Controlled Study,” Phytotherapy Research 26, no. 4 (2012): 510–516.
V. D. E. Simone and O. Pagani, “Pregnancy after Breast Cancer: Hope after the Storm,” Minerva Ginecologica 69, no. 6 (December 2017): 597–607.
H. A. Azim et al., “Safety of Pregnancy Following Breast Cancer Diagnosis: A Meta-analysis of 14 Studies,” European Journal of Cancer 47, no. 1 (2011): 74–83.
P. Fani, “Breastfeeding and Breast Cancer,” Health Science Journal 6, no. 4 (October – December 2012): 610.
O. G. Palesh et al., “A Longitudinal Study of Depression, Pain, and Stress as Predictors of Sleep Disturbance among Women with Metastatic Breast Cancer,” Biological Psychology 75, no. 1 (April 2007): 37–44.
F. N. Bokhari et al., “Pilot Study of a Survey to Identify the Prevalence of and Risk Factors for Chronic Neuropathic Pain Following Breast Cancer Surgery,” Oncology Nursing Forum 39, no. 2 (March 2012): E141–E149.
M. C. Lauridsen, P. Christiansen, and I. B. Hessov, “The Effect of Physiotherapy on Shoulder Function in Patients Surgically Treated for Breast Cancer: A Randomized Study,” Acta Oncologica 44, no. 5 (2005): 449–457.
M. T. Lacomba et al., “Axillary Web Syndrome after Axillary Dissection in Breast Cancer: A Prospective Study,” Breast Cancer Research and Treatment 117, no. 3 (2009): 625–630.
K. M. Mustian et al., “A 4-Week Home-Based Aerobic and Resistance Exercise Program during Radiation Therapy: A Pilot Randomized Clinical Trial,” Journal of Supportive Oncology 7, no. 5 (September – October 2009): 158–167; I. CantareroVillanueva et al., “Effectiveness of Water Physical Therapy on Pain, Pressure Pain Sensitivity, and Myofascial Trigger Points in Breast Cancer Survivors: A Randomized, Controlled Clinical Trial,” Pain Medicine 13, no. 11 (November 2012): 1509–1519.
P. F. Pradat et al., “Radiation-Induced Neuropathies: Collateral Damage of Improved Cancer Prognosis,” Revue Neurologique 168 (2012): 939–950.
C. P. Watson and R. J. Evans, “The Postmastectomy Pain Syndrome and Topical Capsaicin: A Randomized Trial,” Pain 51, no. 3 (December 1992): 375–379.
H. S. Smith and S. X. Wu, “Persistent Pain after Breast Cancer Treatment,” Annals of Palliative Medicine 1, no. 3 (2013): 182–194.
T. S. Alster and E. L. Tanzi, “Hypertrophic Scars and Keloids,” American Journal of Clinical Dermatology 4, no. 4 (2003): 235–243.
M. G. Khouri et al., “Cancer Therapy – Induced Cardiac Toxicity in Early Breast Cancer,” Circulation 126, no. 23 (2012): 2749–2763.
I. F. Tannock et al., “Cognitive Impairment Associated with Chemotherapy for Cancer: Report of a Workshop,” Journal of Clinical Oncology 22, no. 11 (2004): 2233–2239.
Читать дальше